Fig. 7

a, b Slowing in the “vertical ellipsoid zone width” loss according to study timepoints (T0, T1, T2) in the eye treated with the WJ-MSCs (Table 1, patient 5: left eye). c, d In the right eye of the same patient without WJ-MSCs treatment, “vertical ellipsoid zone width” decreased rapidly leading to blindness during the 1-year follow-up (X-linked retinitis pigmentosa, GTPase regulator [RPGR] mutation)